R D Penn Selected Research

recombinant r-metHuBDNF protein

6/2000

A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R D Penn Research Topics

Disease

2	Parkinsonian Disorders (Parkinsonism) 01/2003 - 11/2000
2	Parkinson Disease (Parkinson's Disease) 11/2000 - 04/2000
1	Anorexia 01/2003
1	Hyponatremia 01/2003
1	Nausea 01/2003
1	Paresthesia (Dysesthesia) 01/2003
1	Vomiting 01/2003
1	Weight Loss (Weight Reduction) 01/2003
1	Huntington Disease (Huntington's Disease) 11/2000
1	Dystonia (Limb Dystonia) 11/2000
1	Dystonic Disorders (Writer's Cramp) 11/2000
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 06/2000
1	Acquired Immunodeficiency Syndrome (AIDS) 03/2000
1	Neoplasms (Cancer) 03/2000
1	Pain (Aches) 03/2000
1	Inflammation (Inflammations) 01/2000

Drug/Important Bio-Agent (IBA)

1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2003
1	recombinant r-metHuBDNF proteinIBA 06/2000
1	ziconotide (Prialt)FDA Link 03/2000
1	Analgesics (Analgesic Drugs)IBA 03/2000
1	Opioid Analgesics (Opioids)IBA 03/2000
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2000

Therapy/Procedure

2	Pallidotomy 11/2000 - 04/2000
1	Injections 01/2003
1	Microelectrodes 11/2000